.png)
XXII ANNUAL CONFERENCE
ON EVIDENCE BASED MANAGEMENT OF CANCERS IN INDIA 2024
As in every cancer subsite, colorectal cancer has seen an explosion of scientific evidence in published literature in the last decade. Research has touched every aspect of management of colorectal cancer from its molecular classification, to the introduction of immunotherapy with its initial dramatic results.
Early rectal cancer has seen significant developments with the introduction of new concepts of elective organ preservation and further refinement of endoscopic and transanal resection utilizing various minimally invasive platforms. Total neoadjuvant therapy is perhaps the new buzzword for locally advanced rectal cancer while advances in radiation oncology with newer techniques of brachytherapy, contact X rays and stereotactic delivery systems have contributed to achieve greater response with an aim for organ preservation.
Complete mesocolic excision, neoadjuvant therapy in locally advanced lesions and radiation therapy in unresectable tumours have changed treatment protocols in colon cancer. Research in the treatment of metastatic disease has further elucidated the role of HIPEC in peritoneal metastasis and established the role and sequence of a number of novel treatment modalities in resectable and unresectable liver metastasis.
The greatest challenge of all medical research is its appropriate and timely translation to clinical practice. This track will objectively present the latest evidence covering nearly every aspect of management of colorectal cancer and though panel discussions with experts in the field will attempt to translate the evidence to practical and implementable changes in practice.
It’s been more than a decade, and hybrid imaging has moved beyond FDG PET, with newer tracers like PSMA, DOTATATE, FAPI to name a few, entering into clinical practice. Staging systems, practice recommendations and appropriateness criteria have undergone multiple iterations and fusion imaging is more often used. Since imaging is the fulcrum of cancer management, it’s time that we revisit our practice over past decade and more, compare it with the guidelines and update the practice policies for future. We shall also discuss the technological advances in imaging, with emergence of PET/MR, Digital PET and SPECT scanners.
Radionuclide therapy has gained strong foothold in the treatment algorithm of certain cancers. NETTER-1 trial paved the way for prospective trials and today there are more than 50 ongoing trials globally, which focus on validating a newer therapeutic radiopharmaceutical. We, in India are blessed to have indigenous production and supply of radio-isotopes putting us at the forefront in this race for developing theranostic tracers. Ou current practice involves I-131, Lu-177 DOTA peptides and Lu-177 PSMA, with many more radiolabelled targets available for research and for commercial use. The time is just right to discuss their potential role and areas where these can make a difference not just in terms of outcome but also in terms of improvement in quality of life.
Overall, with the next decade in view, Theranostics is the way ahead and this seems to be the right time to bring out strong evidence with regards to PET/CT Imaging and Radionuclide therapy
Our track can be attended by –
TATA MEMORIAL HOSPITAL
Dr. E Borges Road, Parel, Mumbai - 400 012 India
Phone: +91-22- 24177000, 24177300, 24161413
Fax: +91-22-24146937
E-mail : This email address is being protected from spambots. You need JavaScript enabled to view it. (for patient care and queries)
This email address is being protected from spambots. You need JavaScript enabled to view it. (for accounts related)
This email address is being protected from spambots. You need JavaScript enabled to view it. (for donors and donation related)
This email address is being protected from spambots. You need JavaScript enabled to view it. (for education and training)
This email address is being protected from spambots. You need JavaScript enabled to view it. (for administrative - HRD matters)
Copyright © 2016 Tata Memorial Centre. All rights reserved.This website can be best viewed in Microsoft Internet Explorer 9.0+, Chrome, Firefox
Designed and Developed by Mindspace Software Technologies Pvt. Ltd.
3611722 (1780)
